Pradaxa (dabigatran) is an oral anticoagulant (blood thinner) primarily used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (Afib). It is also used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), and to prevent clots following hip or knee replacement surgery.
